Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Kevin K C Hung, Colin A Graham, Ronson S L Lo, Yuk Ki Leung, Ling Yan Leung, S Y Man, W K Woo, Giles N Cattermole, Timothy H Rainer, Kevin K C Hung, Colin A Graham, Ronson S L Lo, Yuk Ki Leung, Ling Yan Leung, S Y Man, W K Woo, Giles N Cattermole, Timothy H Rainer
Abstract
Background: Soft tissue injuries commonly present to the emergency department (ED), often with acute pain. They cause significant suffering and morbidity if not adequately treated. Paracetamol and ibuprofen are commonly used analgesics, but it remains unknown if either one or the combination of both is superior for pain control.
Objectives: To investigate the analgesic effect of paracetamol, ibuprofen and the combination of both in the treatment of soft tissue injury in an ED, and the side effect profile of these drugs.
Methods: Double-blind, double dummy, placebo-controlled randomised controlled trial. 782 adult patients presenting with soft tissue injury without obvious fractures attending the ED of a university hospital in the New Territories of Hong Kong were recruited. Patients were randomised using a random number table into three parallel arms of paracetamol only, ibuprofen only and a combination of paracetamol and ibuprofen in a 1:1:1 ratio. The primary outcome measure was pain score at rest and on activity in the first 2 hours and first 3 days. Data was analysed on an intention to treat basis.
Results: There was no statistically significant difference in pain score in the initial two hours between the three groups, and no clinically significant difference in pain score in the first three days.
Conclusion: There was no difference in analgesic effects or side effects observed using oral paracetamol, ibuprofen or a combination of both in patients with mild to moderate pain after soft tissue injuries attending the ED.
Trial registration: The study is registered with ClinicalTrials.gov (no. NCT00528658).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- National Guideline Centre (UK). Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence; 2016.
- Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Annals of Internal Medicine. 2007;147(7):505–14.
- Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. European Spine Journal. 2010;19(12):2075–94. doi:
- Wedmore IS, Charette J. Emergency department evaluation and treatment of ankle and foot injuries. Emergency Medicine Clinics of North America. 2000;18(1):85–113.
- Rubin A, Sallis R. Evaluation and diagnosis of ankle injuries. American Family Physician. 1996;54(5):1609–18.
- Ducharme J. Acute pain and pain control: state of the art. Annals of Emergency Medicine. 2000;35(6):592–603.
- Jantos TJ, Paris PM, Menegazzi JJ, Yealy DM. Analgesic practice for acute orthopedic trauma pain in Costa Rican emergency departments. Annals of Emergency Medicine. 1996;28(2):145–50.
- Ferreira SH. Prostaglandins, aspirin-like drugs, and analgesia. Nature 1972;240(102):200–3.
- British Medical Association. British National Formulary: 45 London, 2004.
- Benedetti C, Butler SH. Systemic analgesics In Bonica JJ (Ed): The Management of Pain, ed 2 Philadelphia, Lee and Febiger, 1990:1640–1675.
- Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine. 1991;114(4):257–63.
- Garcia Rodriguez LA, Jick K. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti- inflammatory drugs. Lancet 1994;343(8900):769–72.
- Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343(8905):1075–8.
- Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea: outcome trials reviewed. American Journal of Obstetrics and Gynecology. 1984;148(1):96–103.
- Gøtzsche PC. Non-steroidal anti-inflammatory drugs. BMJ: British Medical Journal. 2000;320(7241):1058
- Collins S, Moore RA, McQuay HJ, Wiffen PJ, Rees J, Derry S. Single dose oral ibuprofen for acute postoperative pain in adults. The Cochrane Library; 2000.
- Rømsing J, Østergaard D, Drozdziewicz D, Schultz P, Ravn G. Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients. Acta Anaesthesiologica Scandinavica. 2000;44(3):291–5.
- Péez-Gutthann S, García-Rodríguez LA, Duque-Oliart A, Varas-Lorenzo C. Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1999;19(7):854–9.
- Davies NM, Skjodt NM. Choosing the right nonsteroidal anti-inflammatory drug for the right patient. Clinical Pharmacokinetics. 2000;38(5):377–92. doi:
- Kirkwood BR. Sampling methods In: Essentials of Medical Statistics. Oxford: Blackwell Science; 1988. p. 167–172.
- Bland M. An introduction to medical statistics. 2nd ed Oxford Publications; 1995.
- Huskisson EC. Measurement of pain. The Lancet. 1974;304(7889):1127–31.23.
- Moore R, Straube S, Aldington D. Pain measures and cut-offs–‘no worse than mild pain’as a simple, universal outcome. Anaesthesia. 2013;68(4):400–12. doi:
- Todd KH, Funk JP. The minimum clinically important difference in physician–assigned visual analog pain scores. Academic Emergency Medicine. 1996;3(2):142–6.
- Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Annals of Emergency Medicine. 1996;27(4):485–9.
- Woo WW, Man SY, Lam PK, Rainer TH. Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine. 2005;46(4):352–61.
- Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CW, Day RO et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015;350:h1225 doi:
- Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. European Journal of Pain. 2015;19(9):1213–23. doi:
- Derry CJ, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. The Cochrane Library; 2009.
- Moore RA, Derry S, Straube S, Ireson-Paine J, Wiffen PJ. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. PAIN. 2014;155(1):14–21. doi:
- World Health Organization. Cancer Pain Relief. Geneva, Switzerland: World Health Organization; 1986.
- Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults—an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;(9):CD008659 doi:
- Bondarsky EE, Domingo AT, Matuza NM, Taylor MB, Thode HC, Singer AJ. Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine. 2013;31(9):1357–60. doi:
- Chan FK, Sung JJ, Chung SS, To KF, Yung MY, Leung VK, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. The Lancet. 1997;350(9083):975–9.
Source: PubMed